2010
DOI: 10.1007/s00277-010-1139-2
|View full text |Cite
|
Sign up to set email alerts
|

Combined therapy associating systemic platinum-based chemotherapy and local radiotherapy into the treatment of primary intraocular lymphoma

Abstract: Ianotto, Christian Berthou. Combined therapy associating systemic platinum-based chemotherapy and local radiotherapy into the treatment of primary intraocular lymphoma.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 10 publications
0
3
0
Order By: Relevance
“…46 Treatment of humans with primary intraocular lymphoma has not been standardized because of the low number of reported cases. However, systemic, [47][48][49] intrathecal, 50,51 and intraocular [52][53][54][55][56] administration of chemotherapeutic drugs with or without adjunctive orbital radiation therapy [57][58][59] have been used. Cytosine arabinoside and methotrexate are the most commonly used chemotherapeutic agents because they penetrate the blood-ocular barrier.…”
Section: Discussionmentioning
confidence: 99%
“…46 Treatment of humans with primary intraocular lymphoma has not been standardized because of the low number of reported cases. However, systemic, [47][48][49] intrathecal, 50,51 and intraocular [52][53][54][55][56] administration of chemotherapeutic drugs with or without adjunctive orbital radiation therapy [57][58][59] have been used. Cytosine arabinoside and methotrexate are the most commonly used chemotherapeutic agents because they penetrate the blood-ocular barrier.…”
Section: Discussionmentioning
confidence: 99%
“…These drugs have been investigated and showed effectiveness [23-26]. A combination of chemotherapy and radiation therapy is also applicable [27]. …”
Section: Discussionmentioning
confidence: 99%
“…14,163,190 High dose methotrexate is the most active drug, producing a response rate of up to 72% when used alone and up to 94e100% in combinations. 16,175,193 Osmotic blood brain barrier disruption to increase brain penetration of chemotherapy is associated with non-sight threatening maculopathy.…”
Section: Chemotherapymentioning
confidence: 99%